Glu-Sense

Glu-Sense is an Israeli medical technology company developing a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes. The company's proprietary technology is based on a genetically engineered fluorescent protein that acts as a glucose-binding sensor, providing high sensitivity and stability. Unlike current CGM systems that require weekly sensor replacements, Glu-Sense's injectable sensor is designed to function accurately for several months. This approach aims to improve patient compliance and quality of life by reducing the burden of frequent sensor changes. The company is currently advancing its technology through pre-clinical stages toward human clinical trials.